Predicting radiation side effects in prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial studies whether a blood test can predict which patients may have side effects from radiation therapy for prostate cancer. It is for men 60 and older with low- or intermediate-risk prostate cancer that has not spread.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 60 years old or older.
- You have localized prostate cancer that is low or intermediate risk (not high risk or spread).
- Your doctor has recommended radiation therapy for your cancer.
- You speak French and have French national health insurance.
- You have not had surgery on your prostate or digestive system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of radiation therapy (SBRT and LDR brachytherapy) for men with low-risk or favorable intermediate-risk prostate cancer. The goal is to see which treatment causes fewer side effects.
This study follows people with prostate cancer who receive radiation to understand what side effects and quality-of-life changes happen over time. It may help improve standard follow-up care by better tracking radiation-related toxicity.
This trial tests a more concentrated radiation schedule for early-stage prostate cancer, using an extra high-dose “boost” delivered from inside the body. It may help by treating the prostate more precisely while aiming to keep side effects manageable.
This trial tests whether adding hormone therapy (ADT) to stereotactic body radiation therapy (SBRT) works better than SBRT alone for men with a specific type of prostate cancer called 'unfavorable intermediate risk.' The goal is to see if the combination helps control the cancer better.
This trial tests if giving fewer radiation treatments using a special MRI-guided machine is safe and effective for men with prostate cancer. It may help reduce side effects while still controlling the cancer.
This study looks at whether re-treating prostate cancer with radiation (after it came back) can be done safely and how side effects affect people. It also checks whether this approach is practical to carry out, especially for urinary side effects and comfort during the process.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.